Norwich Medical School, Floor 2, Bob Champion Research and Education Building, University of East Anglia, Norwich, NR4 7UQ, UK.
Division of Women's Health, North Wing, St Thomas' Campus, Kings College London, London, UK.
Diabetologia. 2017 Sep;60(9):1668-1677. doi: 10.1007/s00125-017-4314-3. Epub 2017 Jun 8.
AIMS/HYPOTHESIS: The aim of this prospective nationwide study was to examine antenatal pregnancy care and pregnancy outcomes in women with type 1 and type 2 diabetes, and to describe changes since 2002/2003.
This national population-based cohort included 3036 pregnant women with diabetes from 155 maternity clinics in England and Wales who delivered during 2015. The main outcome measures were maternal glycaemic control, preterm delivery (before 37 weeks), infant large for gestational age (LGA), and rates of congenital anomaly, stillbirth and neonatal death.
Of 3036 women, 1563 (51%) had type 1, 1386 (46%) had type 2 and 87 (3%) had other types of diabetes. The percentage of women achieving HbA < 6.5% (48 mmol/mol) in early pregnancy varied greatly between clinics (median [interquartile range] 14.3% [7.7-22.2] for type 1, 37.0% [27.3-46.2] for type 2). The number of infants born preterm (21.7% vs 39.7%) and LGA (23.9% vs 46.4%) were lower for women with type 2 compared with type 1 diabetes (both p < 0.001). The prevalence rates for congenital anomaly (46.2/1000 births for type 1, 34.6/1000 births for type 2) and neonatal death (8.1/1000 births for type 1, 11.4/1000 births for type 2) were unchanged since 2002/2003. Stillbirth rates are almost 2.5 times lower than in 2002/2003 (10.7 vs 25.8/1000 births for type 1, p = 0.0012; 10.5 vs 29.2/1000 births for type 2, p = 0.0091).
CONCLUSIONS/INTERPRETATION: Stillbirth rates among women with type 1 and type 2 diabetes have decreased since 2002/2003. Rates of preterm delivery and LGA infants are lower in women with type 2 compared with type 1 diabetes. In women with type 1 diabetes, suboptimal glucose control and high rates of perinatal morbidity persist with substantial variations between clinics.
Further details of the data collection methodology, individual clinic data and the full audit reports for healthcare professionals and service users are available from http://content.digital.nhs.uk/npid .
目的/假设:本前瞻性全国性研究旨在探讨 1 型和 2 型糖尿病女性的产前妊娠护理和妊娠结局,并描述自 2002/2003 年以来的变化。
该全国性基于人群的队列纳入了英格兰和威尔士 155 家产科诊所的 3036 名 2015 年分娩的糖尿病孕妇。主要结局指标为产妇血糖控制、早产(<37 周)、巨大儿(LGA)和先天性畸形、死胎和新生儿死亡的发生率。
在 3036 名女性中,1563 名(51%)患有 1 型糖尿病,1386 名(46%)患有 2 型糖尿病,87 名(3%)患有其他类型的糖尿病。早期妊娠时达到 HbA1c<6.5%(48mmol/mol)的女性比例在各诊所之间差异很大(1 型糖尿病的中位数[四分位间距]为 14.3%[7.7-22.2],2 型糖尿病为 37.0%[27.3-46.2])。与 1 型糖尿病相比,2 型糖尿病女性的早产儿(21.7%比 39.7%)和 LGA(23.9%比 46.4%)的发生率较低(均 p<0.001)。自 2002/2003 年以来,先天性畸形(1 型糖尿病为 46.2/1000 例,2 型糖尿病为 34.6/1000 例)和新生儿死亡(1 型糖尿病为 8.1/1000 例,2 型糖尿病为 11.4/1000 例)的发生率保持不变。与 2002/2003 年相比,死胎率几乎降低了 2.5 倍(1 型糖尿病为 10.7/1000 例,p=0.0012;2 型糖尿病为 10.5/1000 例,p=0.0091)。
结论/解释:自 2002/2003 年以来,1 型和 2 型糖尿病女性的死胎率有所下降。与 1 型糖尿病相比,2 型糖尿病女性的早产和 LGA 婴儿发生率较低。在 1 型糖尿病女性中,血糖控制仍然不理想,围产期发病率仍然较高,各诊所之间存在很大差异。
有关数据收集方法、个别诊所数据以及医疗保健专业人员和服务用户的完整审核报告的更多详细信息可从 http://content.digital.nhs.uk/npid 获得。